Liu Ye's most recent trade in EyePoint Pharmaceuticals Inc was a trade of 1,910,500 Common Stock, $0.001 par value done at an average price of $19.5 . Disclosure was reported to the exchange on Jan. 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| EyePoint Pharmaceuticals Inc | Ye Liu | Director | Sale of securities on an exchange or to another person at price $ 19.45 per share. | 11 Jan 2024 | 1,910,500 | 100,221 (0%) | 1% | 19.5 | 37,159,225 | Common Stock, $0.001 par value |
| EyePoint Pharmaceuticals Inc | Liu Ye | Director | Sale of securities on an exchange or to another person at price $ 19.91 per share. | 05 Dec 2023 | 733,758 | 2,276,963 (1%) | 0% | 19.9 | 14,609,122 | Common Stock, $0.001 par value |
| EyePoint Pharmaceuticals Inc | Liu Ye | Director | Sale of securities on an exchange or to another person at price $ 18.41 per share. | 05 Dec 2023 | 266,242 | 2,010,721 (1%) | 0% | 18.4 | 4,901,515 | Common Stock, $0.001 par value |
| EyePoint Pharmaceuticals Inc | Ye Liu | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 30 May 2023 | 1 | 3,010,721 (2%) | 0% | 6 | 6 | Common Stock, $0.001 par value |